Feature|Articles|August 16, 2024
- Pharmaceutical Executive: July/August 2024
- Volume 44
- Issue 7/8
Pharmaceutical Executive: July/August 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive July/August 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
An AI Pulse Checkabout 2 years ago
Divergent Paths: Pharm Exec Profiles Five Recent Drug Launchesabout 2 years ago
A Promising Option: Exxuaabout 2 years ago
Opening the Door: Omvohabout 2 years ago
'Marked’ for Stardom?: Truqapabout 2 years ago
Branching Off: Wegovyabout 2 years ago
A Formidable First: Winrevairabout 2 years ago
The Future of Launch Excellence is Generative AIabout 2 years ago
From Potential to Value: Carving a Slice of the CGT ‘PIE'about 2 years ago
Big Bets, Bold StepsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5